Portfolio (Quarterly)
Guide ↗
DoubleLine ETF Adviser LP
· CIK 0001959989| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & CO | Healthcare | 9,802.0 | $9.0M | 3.43% | NEW | — | $919.77 | +15.8% |
| 2 | JNJ | JOHNSON & JOHNSON | Healthcare | 29,674.0 | $7.3M | 2.76% | NEW | — | $244.44 | -4.1% |
| 3 | ABBV | ABBVIE INC | Healthcare | 21,804.0 | $4.7M | 1.80% | NEW | — | $217.49 | -0.8% |
| 4 | MRK | MERCK & CO INC | Healthcare | 30,910.0 | $3.7M | 1.42% | NEW | — | $120.29 | +1.8% |
| 5 | UNH | UNITEDHEALTH GROUP INC | Healthcare | 11,362.0 | $3.1M | 1.17% | NEW | — | $270.59 | +43.6% |
| 6 | AMGN | AMGEN INC | Healthcare | 6,730.0 | $2.4M | 0.90% | NEW | — | $351.85 | -3.6% |
| 7 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 4,704.0 | $2.3M | 0.88% | NEW | — | $491.53 | -8.8% |
| 8 | ABT | ABBOTT LABORATORIES | Healthcare | 21,921.0 | $2.3M | 0.86% | NEW | — | $102.67 | -14.9% |
| 9 | GILD | GILEAD SCIENCES INC | Healthcare | 15,600.0 | $2.2M | 0.83% | NEW | — | $139.37 | -3.6% |
| 10 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 4,467.0 | $2.1M | 0.78% | NEW | — | $460.99 | -5.0% |
| 11 | PFE | PFIZER INC | Healthcare | 72,027.0 | $2.0M | 0.77% | NEW | — | $28.08 | -7.8% |
| 12 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 26,054.0 | $1.6M | 0.60% | NEW | — | $60.65 | -2.0% |
| 13 | DHR | DANAHER CORP DEL | Healthcare | 7,960.0 | $1.5M | 0.57% | NEW | — | $189.60 | -9.3% |
| 14 | SYK | STRYKER CORPORATION | Healthcare | 4,409.0 | $1.4M | 0.55% | NEW | — | $328.59 | -3.7% |
| 15 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 3,233.0 | $1.4M | 0.55% | NEW | — | $446.54 | -2.7% |
| 16 | MCK | MCKESSON CORP | Healthcare | 1,582.0 | $1.4M | 0.52% | NEW | — | $865.36 | -11.5% |
| 17 | MDT | MEDTRONIC PLC | Healthcare | 15,699.0 | $1.4M | 0.52% | NEW | — | $86.65 | -9.3% |
| 18 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 18,977.0 | $1.2M | 0.45% | NEW | — | $62.75 | -7.9% |
| 19 | CVS | CVS HEALTH CORP | Healthcare | 16,464.0 | $1.2M | 0.45% | NEW | — | $71.82 | +29.9% |
| 20 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 1,316.0 | $1.0M | 0.39% | NEW | — | $772.64 | -17.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Communication Services
25.6%
Consumer Cyclical
24.9%
Healthcare
24.7%
Real Estate
24.2%
Technology
0.6%
Industrials
0.0%
Consumer Defensive
0.0%